Featured Videos |view more
In this video, two MUSC Hollings Cancer Center neuro-oncologists, Scott M. Lindhorst, M.D., and David M. Cachia, M.D., discuss their experience with TTFields and the clinical trials they are leading in patients who have failed Avastin therapy.
William A. Vandergrift, M.D., discusses, Laser ablation, in which a laser is inserted through a screw fitted in a very small hole in the skull and guided to the appropriate area of the brain, which offers a minimally invasive alternative for epilepsy.
MUSC Health neurosurgeon Istvan Takacs, M.D., describes how deep brain stimulation (DBS) works, the advantages of performing it awake and how it can dramatically affect the quality of life of patients with movement disorders such as Parkinson’s disease.
Featured Documents |view more
In 2015, five landmark clinical trials provided the evidence that mechanical thrombectomy using stent retrievers was safe and effective for certain patients with acute ischemic stroke.
Two competing hospitals will pool resources to use telestroke and other innovative approaches to reduce barriers to stroke care and improve quality.
Therapies for a variety of conditions, ranging from Parkinson’s disease to depression, have been developed that intervene in that communication by sending a electrical charge via an implanted microprocessor.
Stroke patients are faced with danger on two fronts. First, when a clot blocks blood flow, brain tissue is starved of oxygen and begins to die.
MUSC Health Neurosciences ranks first in the Southeast and second in the country in National Institutes of Health neuroscience research funding. It places researchers and clinicians at each other’s side in an effort to realize the clinical promise of cutting-edge research. As a consistent leader in neuroscience advances, MUSC Health is: